Emergence of fluoroquinolone-resistant tuberculosis in New York City.
about
Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysisEmpirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areasCurrent prospects for the fluoroquinolones as first-line tuberculosis therapyFluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophagesMutant prevention concentration as a measure of fluoroquinolone potency against mycobacteriaEfflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatisFluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosityIntrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpATuberculosis: 9. Treatment.DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model.Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai.Fluoroquinolones and tuberculosis.Current status and future development of antitubercular chemotherapy.Molecular epidemiology of tuberculosis: current insights.Recent developments in the treatment of tuberculosis.Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005-2010.A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.Role of mycobacterial efflux transporters in drug resistance: an unresolved question.Rapid identification of extensively and extremely drug resistant tuberculosis from multidrug resistant strains; using PCR-RFLP and PCR-SSCP.Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.Key issues in multidrug-resistant tuberculosis.Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China.Is repositioning of drugs a viable alternative in the treatment of tuberculosis?Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays.Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining regionAntimicrobial agent resistance in mycobacteria: molecular genetic insights.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.The treatment of tuberculosis: current status and future prospects.Avoiding fluoroquinolone resistance. Strategies for primary care practice.Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.
P2860
Q24554274-377D91F5-DE04-4C65-BA62-A9B1E05684A8Q24683345-95802E4F-5508-4BEC-BECF-D1BF4B65ABFAQ26823843-A12329C2-8816-46B9-8DC3-A900F7D8BDC4Q28343182-D790BBD0-FE5C-438F-AE09-636FC963C71BQ28344939-E3C6F737-3E76-42C1-9F53-73A0C4974C68Q28378761-DFD87FF7-CDCC-4582-8C93-6764E67274BDQ28379135-B76D54DB-C99E-44BE-94D6-A28932AAECF1Q32035273-D272D5ED-3021-4483-9F77-02F4726FA753Q33729210-812690A2-B125-418B-A0DE-294DC0B2A8B6Q33740527-9F5F4C3C-EC45-45C1-BF81-C27C35B10639Q33935424-3296240A-C7AA-4854-B1C5-086903CB9285Q34453089-0CD8519B-0A53-432D-818B-48387C65B879Q34519143-64734B28-2B33-4767-A123-BAF2618A9920Q34768541-24192362-0E92-490A-8973-06BE09E2B112Q35070843-586BC78F-1267-455F-B88A-3BC03DC6D3A2Q35185753-A9DDDC67-3298-4E7C-BA71-47F471AD687CQ35273635-BCE35B5A-9FB6-49B8-8598-2FCBD7742C32Q35673493-9BC6DE8F-BBEE-4E30-98A0-F1091BF54A0EQ35821755-A4521658-4595-4B17-B9C7-92353430EF44Q35849799-B6A826F3-238E-473D-9268-233AF9126562Q35867806-EBC4995E-7FB3-4CF5-84D0-1EDD7C1FFC87Q36378353-9465EC9F-B6BD-4344-91A1-8E95A7BD889FQ36425928-F336EB01-0FAD-4D2F-BF3D-0E56D0C70468Q36574542-3C1A7791-A7E3-4244-A3F2-0152384F2974Q36895711-5BCCC52D-82B1-4AFF-82C0-B507F61321ACQ36960077-804BB558-24A3-4F47-987D-C2565E180D8DQ37544551-05536C92-54ED-40C7-9936-6C8538060E30Q38053000-C2AEC91F-88DF-4A08-97ED-BFFD112C4CF3Q39218305-F132CB33-89CA-4D21-ACE1-F26F97BA7164Q39478070-8FA926EB-89BE-409E-8910-3F9DC851E85FQ39820619-1222FF3E-8165-4F97-99CE-722F8CEF20A6Q39967041-A5571017-FFFB-41AE-B41D-D94039CE1C1BQ40408985-48FA08FF-4350-40C2-8CAA-CD0E562D01B8Q40903054-E65BA6CA-A23E-418A-ADE9-3981EFD567BBQ41901445-2C32CEFB-D22C-48E9-A9DC-BE162F91737BQ44007889-D0EC5013-80C0-4D20-9B14-FBA52B575D4A
P2860
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
@en
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
@nl
type
label
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
@en
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
@nl
prefLabel
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
@en
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
@nl
P2093
P1433
P1476
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
@en
P2093
A Ebrahimzadeh
B N Kreiswirth
J M Musser
T R Frieden
P304
P356
10.1016/S0140-6736(95)90980-X
P407
P577
1995-05-01T00:00:00Z